These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32427350)

  • 1. Utility of genetic testing for therapeutic decision-making in adults with epilepsy.
    Johannesen KM; Nikanorova N; Marjanovic D; Pavbro A; Larsen LHG; Rubboli G; Møller RS
    Epilepsia; 2020 Jun; 61(6):1234-1239. PubMed ID: 32427350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the best candidates for next-generation sequencing-based gene panel for evaluation of early-onset epilepsy.
    Lee J; Lee C; Ki CS; Lee J
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1376. PubMed ID: 32613771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and comorbidities of SCN1A-related seizure disorders.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Small Molecule Treatment for Genetic Epilepsies.
    Goldberg EM
    Neurotherapeutics; 2021 Jul; 18(3):1490-1499. PubMed ID: 34431030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCN1A testing for epilepsy: application in clinical practice.
    Hirose S; Scheffer IE; Marini C; De Jonghe P; Andermann E; Goldman AM; Kauffman M; Tan NC; Lowenstein DH; Sisodiya SM; Ottman R; Berkovic SF;
    Epilepsia; 2013 May; 54(5):946-52. PubMed ID: 23586701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of multigene panel testing in adults with epilepsy and intellectual disability.
    Borlot F; de Almeida BI; Combe SL; Andrade DM; Filloux FM; Myers KA
    Epilepsia; 2019 Aug; 60(8):1661-1669. PubMed ID: 31273778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
    Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
    Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When should clinicians order genetic testing for Dravet syndrome?
    Fountain-Capal JK; Holland KD; Gilbert DL; Hallinan BE
    Pediatr Neurol; 2011 Nov; 45(5):319-23. PubMed ID: 22000312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis.
    Martin HC; Kim GE; Pagnamenta AT; Murakami Y; Carvill GL; Meyer E; Copley RR; Rimmer A; Barcia G; Fleming MR; Kronengold J; Brown MR; Hudspith KA; Broxholme J; Kanapin A; Cazier JB; Kinoshita T; Nabbout R; ; Bentley D; McVean G; Heavin S; Zaiwalla Z; McShane T; Mefford HC; Shears D; Stewart H; Kurian MA; Scheffer IE; Blair E; Donnelly P; Kaczmarek LK; Taylor JC
    Hum Mol Genet; 2014 Jun; 23(12):3200-11. PubMed ID: 24463883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of neonatal-onset epilepsies.
    Cornet MC; Cilio MR
    Handb Clin Neurol; 2019; 162():415-433. PubMed ID: 31324323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy.
    Wang JW; Shi XY; Kurahashi H; Hwang SK; Ishii A; Higurashi N; Kaneko S; Hirose S;
    Epilepsy Res; 2012 Dec; 102(3):195-200. PubMed ID: 23195492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EPIGENE network: A French initiative to harmonize and improve the nationwide diagnosis of monogenic epilepsies.
    Arnaud L; Abi Warde MT; Barcia G; de Bellescize J; Chatron N; Faoucher M; de Saint Martin A; Héron D; Jedraszak G; Lacoste C; Lèbre AS; Jenneson-Lyver M; Labalme A; Leguern E; Mignot C; Milh M; Nabbout R; Nava C; Panagiotakaki E; Piton A; Schaefer E; Thevenon J; Villard L; Ville D; Lesca G
    Eur J Med Genet; 2022 Mar; 65(3):104445. PubMed ID: 35091117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic gap in genetic epilepsies: A matter of age.
    Aledo-Serrano A; García-Morales I; Toledano R; Jiménez-Huete A; Parejo B; Anciones C; Mingorance A; Ramos P; Gil-Nagel A
    Epilepsy Behav; 2020 Oct; 111():107266. PubMed ID: 32610249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Genome Sequencing Among Kazakhstani Children with Early-Onset Epilepsy Revealed New Gene Variants and Phenotypic Variability.
    Bayanova M; Bolatov AK; Bazenova A; Nazarova L; Nauryzbayeva A; Tanko NM; Rakhimova S; Satvaldina N; Samatkyzy D; Kozhamkulov U; Kairov U; Akilzhanova A; Sarbassov D
    Mol Neurobiol; 2023 Aug; 60(8):4324-4335. PubMed ID: 37095367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Genetic Testing on Therapeutic Decision-Making in Childhood-Onset Epilepsies-a Study in a Tertiary Epilepsy Center.
    Bayat A; Fenger CD; Techlo TR; Højte AF; Nørgaard I; Hansen TF; Rubboli G; Møller RS; Group DCCRS
    Neurotherapeutics; 2022 Jul; 19(4):1353-1367. PubMed ID: 35723786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Diagnosis of Dravet Syndrome Using Next Generation Sequencing-Based Epilepsy Gene Panel Testing.
    Lee J; Lee C; Park WY; Lee J
    Ann Clin Lab Sci; 2020 Sep; 50(5):625-637. PubMed ID: 33067208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders.
    Lindy AS; Stosser MB; Butler E; Downtain-Pickersgill C; Shanmugham A; Retterer K; Brandt T; Richard G; McKnight DA
    Epilepsia; 2018 May; 59(5):1062-1071. PubMed ID: 29655203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a Dynamic Genetic Testing Approach for Childhood-Onset Epilepsy.
    Balciuniene J; DeChene ET; Akgumus G; Romasko EJ; Cao K; Dubbs HA; Mulchandani S; Spinner NB; Conlin LK; Marsh ED; Goldberg E; Helbig I; Sarmady M; Abou Tayoun A
    JAMA Netw Open; 2019 Apr; 2(4):e192129. PubMed ID: 30977854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Debate: Does genetic information in humans help us treat patients? PRO--genetic information in humans helps us treat patients. CON--genetic information does not help at all.
    Delgado-Escueta AV; Bourgeois BF
    Epilepsia; 2008 Dec; 49 Suppl 9():13-24. PubMed ID: 19087113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis.
    Gall K; Izzo E; Seppälä EH; Alakurtti K; Koskinen L; Saarinen I; Singh A; Myllykangas S; Koskenvuo J; Alastalo TP
    PLoS One; 2021; 16(9):e0255933. PubMed ID: 34469436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.